John Lee
2017 - PhaseBio Pharmaceuticals
In 2017, John Lee earned a total compensation of $370.4K as Chief Medical Officer at PhaseBio Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $50,985 |
|---|---|
| Option Awards | $11,188 |
| Salary | $307,500 |
| Other | $711 |
| Total | $370,384 |
Lee received $307.5K in salary, accounting for 83% of the total pay in 2017.
Lee also received $51K in non-equity incentive plan, $11.2K in option awards and $711 in other compensation.
Rankings
In 2017, John Lee's compensation ranked 12,796th out of 14,666 executives tracked by ExecPay. In other words, Lee earned more than 12.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,796 out of 14,666 | 13th |
Division Manufacturing | 5,026 out of 5,768 | 13th |
Major group Chemicals And Allied Products | 1,842 out of 2,074 | 11th |
Industry group Drugs | 1,533 out of 1,730 | 11th |
Industry Pharmaceutical Preparations | 1,186 out of 1,329 | 11th |
Source: SEC filing on April 5, 2019.
Lee's colleagues
We found two more compensation records of executives who worked with John Lee at PhaseBio Pharmaceuticals in 2017.
News
Marathon Patent Group CFO Hugh Gallagher receives $4.8M in 2022
June 23, 2023
Decibel Therapeutics CEO Laurence Reid's 2022 pay jumps 54% to $1.2M
April 28, 2023
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2021 pay slips 13% to $1.5M
April 22, 2022
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2019 pay jumps 102% to $1.2M
April 24, 2020
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2018 pay jumps 37% to $596K
April 5, 2019